For its fourth fiscal quarter (ending December 31), Axogen Inc (NASDAQ: AXGN) has reported a -111% decline in E.P.S. from $-0.09 a year ago to $0.01 in the current quarter. For the latest four quarters […]
For its fourth fiscal quarter (ending December 31), UFP Technologies Inc (NASDAQ: UFPT) has reported a 40% increase in E.P.S. from $1.52 a year ago to $2.13 in the current quarter. E.P.S. were $7.69 for […]
For its fourth fiscal quarter (ending December 31), Travelzoo (NASDAQ: TZOO) has reported a 12% increase in E.P.S. from $0.24 a year ago to $0.27 in the current quarter. E.P.S. were $1.08 for the latest […]
For its fourth fiscal quarter (ending December 31), Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has reported a 111% increase in E.P.S. from $1.50 a year ago to $3.16 in the current quarter. E.P.S. were $9.06 for […]
Intuit Inc. (NASDAQ: INTU) has reported earnings for its second fiscal quarter (ending January 31) of $1.68 versus $1.26 for the same period a year ago — an increase of 33%. E.P.S. were $10.84 for […]
Interface Inc (NASDAQ: TILE) has reported E.P.S. of $0.37 for its fourth fiscal quarter (ending December 31) versus $0.34 for the same period a year ago — an increase of 9%. For the latest four […]
For its fourth fiscal quarter (ending December 31), Inter Parfums Inc (NASDAQ: IPAR) has reported a 130% increase in E.P.S. from $0.33 a year ago to $0.76 in the current quarter. E.P.S. were $5.13 for […]
Caesars Entertainment Inc (NASDAQ: CZR) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.05 versus a loss $-0.34 for the same period a year ago — a decline of -115%. For […]
Axon Enterprise Inc (NASDAQ: AXON) has reported E.P.S. of $1.77 for its fourth fiscal quarter (ending December 31) versus $0.76 for the same period a year ago — an increase of 133%. For the latest […]
Weis Markets Inc. (NYSE: WMK) has reported E.P.S. of $1.29 for its fourth fiscal quarter (ending December 31) versus $0.76 for the same period a year ago — an increase of 70%. For the latest […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research